Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
Real-time insight on key fixed income and fx markets.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- MNI ResearchMNI Research
Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.
- About Us
Sign up now for free access to this content.
Please enter your details below and select your areas of interest.
- After a more solid start to the Monday session, the equity outlook deteriorated after the London close as the e-mini S&P ebbed through the Friday lows.
- This put index prices at the lowest levels since August 23rd, with next support undercutting at the Aug23 lows of 4433.50 ahead of the 50-dma / 50-day EMA at 4421.21 /4417.10.
- Healthcare names added to the downside pressure, with tech and consumer discretionary sectors also in negative territory. Notable single names adding to the downside pressure include Moderna & Pfizer on a Lancet report suggesting a third round of vaccine boosters may not be necessary and Twitter & Netflix after a Goldman Sachs' re-rating.
- On the continent, performance was more positive, helping most markets rise 0.5% or so. Spain's IBEX-35 outperformed, thanks to sizeable point contributions from Banco Santander, Iberdrola and BBVA.